Therapy Markers

Soluble Fas Antigen Predicts Poor Response To Interferon In Hepatitis C

Published in Hepatitis Weekly, November 19th, 2001

by Sonia Nichols, senior medical writer - Soluble Fas antigen may be related to response to interferon (IFN) in patients with chronic hepatitis C.

"Fas system-mediated cytotoxicity is thought to be involved in the development of liver injury in hepatitis C virus (HCV) infection," commented Kazuyoshi Ohkawa and associates, Osaka University Graduate School of Medicine, in the Journal of Gastroenterology and Hepatology.

After evaluating the Fas system in patients with chronic hepatitis C, Ohkawa and colleagues have identified a strong relationship between the expression of Fas antigen and the way a person with chronic hepatitis C responds to IFN...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-11-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry